CD274 and cancer: Meanwhile, PD-L1 expressionshould be combined with clinicopathologic features representing high mutation load,including advanced age, higher tumor stage and HPV status, to identify more suitableHPV-related cancer cases for anti-PD-1/PD-L1 therapy.